Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses

Authors:

Abstract
No abstract available
Funding Information
  • Novo Nordisk

This publication has 22 references indexed in Scilit: